nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Anisotropine Methylbromide—Valproic Acid—epilepsy syndrome	0.346	1	CrCrCtD
Ipratropium bromide—CHRM3—epilepsy syndrome	0.108	0.329	CbGaD
Ipratropium bromide—CHRM1—epilepsy syndrome	0.101	0.306	CbGaD
Ipratropium bromide—CHRM2—epilepsy syndrome	0.0824	0.25	CbGaD
Ipratropium bromide—CYP2D6—epilepsy syndrome	0.0377	0.115	CbGaD
Ipratropium bromide—SLC22A5—Valproic Acid—epilepsy syndrome	0.0261	0.168	CbGbCtD
Ipratropium bromide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0106	0.0681	CbGbCtD
Ipratropium bromide—CYP3A4—Felbamate—epilepsy syndrome	0.00984	0.0634	CbGbCtD
Ipratropium bromide—CYP3A4—Trimethadione—epilepsy syndrome	0.00984	0.0634	CbGbCtD
Ipratropium bromide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00925	0.0596	CbGbCtD
Ipratropium bromide—CYP2D6—Propofol—epilepsy syndrome	0.00874	0.0563	CbGbCtD
Ipratropium bromide—CYP3A4—Clonazepam—epilepsy syndrome	0.00836	0.0539	CbGbCtD
Ipratropium bromide—CYP3A4—Clobazam—epilepsy syndrome	0.00802	0.0516	CbGbCtD
Ipratropium bromide—CYP3A4—Rufinamide—epilepsy syndrome	0.00682	0.0439	CbGbCtD
Ipratropium bromide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00664	0.0428	CbGbCtD
Ipratropium bromide—CYP3A4—Primidone—epilepsy syndrome	0.0062	0.04	CbGbCtD
Ipratropium bromide—CYP3A4—Phenytoin—epilepsy syndrome	0.00596	0.0384	CbGbCtD
Ipratropium bromide—CYP3A4—Propofol—epilepsy syndrome	0.00556	0.0358	CbGbCtD
Ipratropium bromide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00531	0.0342	CbGbCtD
Ipratropium bromide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00531	0.0342	CbGbCtD
Ipratropium bromide—CYP3A4—Midazolam—epilepsy syndrome	0.00524	0.0337	CbGbCtD
Ipratropium bromide—CYP3A4—Diazepam—epilepsy syndrome	0.00504	0.0324	CbGbCtD
Ipratropium bromide—CYP3A4—Zonisamide—epilepsy syndrome	0.00492	0.0317	CbGbCtD
Ipratropium bromide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00397	0.0256	CbGbCtD
Ipratropium bromide—CYP3A4—Topiramate—epilepsy syndrome	0.00358	0.0231	CbGbCtD
Ipratropium bromide—Anisotropine Methylbromide—CHRM3—epilepsy syndrome	0.000286	0.0809	CrCbGaD
Ipratropium bromide—Anisotropine Methylbromide—CHRM1—epilepsy syndrome	0.000266	0.0755	CrCbGaD
Ipratropium bromide—Anisotropine Methylbromide—CHRM2—epilepsy syndrome	0.000218	0.0616	CrCbGaD
Ipratropium bromide—CHRM2—forebrain—epilepsy syndrome	0.000197	0.0473	CbGeAlD
Ipratropium bromide—Methylscopolamine bromide—CHRM3—epilepsy syndrome	0.000181	0.0514	CrCbGaD
Ipratropium bromide—CHRM2—telencephalon—epilepsy syndrome	0.000181	0.0435	CbGeAlD
Ipratropium bromide—CHRM1—forebrain—epilepsy syndrome	0.000179	0.043	CbGeAlD
Ipratropium bromide—Methylscopolamine bromide—CHRM1—epilepsy syndrome	0.000169	0.0479	CrCbGaD
Ipratropium bromide—CHRM1—telencephalon—epilepsy syndrome	0.000165	0.0396	CbGeAlD
Ipratropium bromide—CHRM5—head—epilepsy syndrome	0.000164	0.0394	CbGeAlD
Ipratropium bromide—CHRM3—forebrain—epilepsy syndrome	0.00016	0.0385	CbGeAlD
Ipratropium bromide—CYP2D6—hindbrain—epilepsy syndrome	0.000157	0.0376	CbGeAlD
Ipratropium bromide—CHRM5—nervous system—epilepsy syndrome	0.000156	0.0374	CbGeAlD
Ipratropium bromide—Scopolamine—CHRM3—epilepsy syndrome	0.000154	0.0437	CrCbGaD
Ipratropium bromide—Trospium—CHRM3—epilepsy syndrome	0.000151	0.0429	CrCbGaD
Ipratropium bromide—CHRM5—central nervous system—epilepsy syndrome	0.00015	0.036	CbGeAlD
Ipratropium bromide—CHRM3—telencephalon—epilepsy syndrome	0.000147	0.0354	CbGeAlD
Ipratropium bromide—Scopolamine—CHRM1—epilepsy syndrome	0.000144	0.0408	CrCbGaD
Ipratropium bromide—Hyoscyamine—CHRM3—epilepsy syndrome	0.000142	0.0401	CrCbGaD
Ipratropium bromide—Trospium—CHRM1—epilepsy syndrome	0.000141	0.04	CrCbGaD
Ipratropium bromide—Methylscopolamine bromide—CHRM2—epilepsy syndrome	0.000138	0.0391	CrCbGaD
Ipratropium bromide—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000134	0.0379	CrCbGaD
Ipratropium bromide—Hyoscyamine—CHRM1—epilepsy syndrome	0.000132	0.0374	CrCbGaD
Ipratropium bromide—SLC22A4—spinal cord—epilepsy syndrome	0.000131	0.0314	CbGeAlD
Ipratropium bromide—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000125	0.0353	CrCbGaD
Ipratropium bromide—Atropine—CHRM3—epilepsy syndrome	0.00012	0.0341	CrCbGaD
Ipratropium bromide—CHRM5—brain—epilepsy syndrome	0.000119	0.0286	CbGeAlD
Ipratropium bromide—Scopolamine—CHRM2—epilepsy syndrome	0.000117	0.0333	CrCbGaD
Ipratropium bromide—Trospium—CHRM2—epilepsy syndrome	0.000115	0.0327	CrCbGaD
Ipratropium bromide—CHRM2—head—epilepsy syndrome	0.000113	0.0271	CbGeAlD
Ipratropium bromide—Atropine—CHRM1—epilepsy syndrome	0.000112	0.0318	CrCbGaD
Ipratropium bromide—Hyoscyamine—CHRM2—epilepsy syndrome	0.000108	0.0306	CrCbGaD
Ipratropium bromide—CHRM2—nervous system—epilepsy syndrome	0.000107	0.0257	CbGeAlD
Ipratropium bromide—SLC22A4—cerebellum—epilepsy syndrome	0.000104	0.0249	CbGeAlD
Ipratropium bromide—CHRM2—central nervous system—epilepsy syndrome	0.000103	0.0247	CbGeAlD
Ipratropium bromide—CHRM1—head—epilepsy syndrome	0.000103	0.0246	CbGeAlD
Ipratropium bromide—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000102	0.0289	CrCbGaD
Ipratropium bromide—CHRM1—nervous system—epilepsy syndrome	9.72e-05	0.0234	CbGeAlD
Ipratropium bromide—SLC22A5—medulla oblongata—epilepsy syndrome	9.7e-05	0.0233	CbGeAlD
Ipratropium bromide—CHRM1—central nervous system—epilepsy syndrome	9.36e-05	0.0225	CbGeAlD
Ipratropium bromide—CHRM3—head—epilepsy syndrome	9.18e-05	0.022	CbGeAlD
Ipratropium bromide—Atropine—CHRM2—epilepsy syndrome	9.17e-05	0.026	CrCbGaD
Ipratropium bromide—CYP2D6—brainstem—epilepsy syndrome	8.98e-05	0.0216	CbGeAlD
Ipratropium bromide—SLC22A5—midbrain—epilepsy syndrome	8.87e-05	0.0213	CbGeAlD
Ipratropium bromide—CHRM3—nervous system—epilepsy syndrome	8.7e-05	0.0209	CbGeAlD
Ipratropium bromide—CYP2D6—forebrain—epilepsy syndrome	8.67e-05	0.0208	CbGeAlD
Ipratropium bromide—SLC22A5—spinal cord—epilepsy syndrome	8.65e-05	0.0208	CbGeAlD
Ipratropium bromide—Methylphenidate—SLC6A4—epilepsy syndrome	8.53e-05	0.0242	CrCbGaD
Ipratropium bromide—Dexmethylphenidate—SLC6A4—epilepsy syndrome	8.53e-05	0.0242	CrCbGaD
Ipratropium bromide—SLC22A4—brain—epilepsy syndrome	8.42e-05	0.0202	CbGeAlD
Ipratropium bromide—CHRM3—central nervous system—epilepsy syndrome	8.38e-05	0.0201	CbGeAlD
Ipratropium bromide—CHRM2—brain—epilepsy syndrome	8.16e-05	0.0196	CbGeAlD
Ipratropium bromide—CYP2D6—telencephalon—epilepsy syndrome	7.97e-05	0.0191	CbGeAlD
Ipratropium bromide—CHRM1—brain—epilepsy syndrome	7.43e-05	0.0179	CbGeAlD
Ipratropium bromide—SLC22A5—cerebellum—epilepsy syndrome	6.86e-05	0.0165	CbGeAlD
Ipratropium bromide—CHRM3—brain—epilepsy syndrome	6.65e-05	0.016	CbGeAlD
Ipratropium bromide—Methylphenidate—CYP2D6—epilepsy syndrome	5.99e-05	0.017	CrCbGaD
Ipratropium bromide—Dexmethylphenidate—CYP2D6—epilepsy syndrome	5.99e-05	0.017	CrCbGaD
Ipratropium bromide—SLC22A5—brain—epilepsy syndrome	5.57e-05	0.0134	CbGeAlD
Ipratropium bromide—Trospium—CYP2D6—epilepsy syndrome	5.28e-05	0.0149	CrCbGaD
Ipratropium bromide—CYP2D6—head—epilepsy syndrome	4.96e-05	0.0119	CbGeAlD
Ipratropium bromide—CYP3A4—nervous system—epilepsy syndrome	4.78e-05	0.0115	CbGeAlD
Ipratropium bromide—CYP2D6—nervous system—epilepsy syndrome	4.71e-05	0.0113	CbGeAlD
Ipratropium bromide—CYP3A4—central nervous system—epilepsy syndrome	4.6e-05	0.0111	CbGeAlD
Ipratropium bromide—CYP2D6—central nervous system—epilepsy syndrome	4.53e-05	0.0109	CbGeAlD
Ipratropium bromide—CYP2D6—cerebellum—epilepsy syndrome	4.43e-05	0.0106	CbGeAlD
Ipratropium bromide—Nausea—Propofol—epilepsy syndrome	4.08e-05	0.000363	CcSEcCtD
Ipratropium bromide—Tension—Gabapentin—epilepsy syndrome	4.07e-05	0.000362	CcSEcCtD
Ipratropium bromide—Vomiting—Fosphenytoin—epilepsy syndrome	4.07e-05	0.000362	CcSEcCtD
Ipratropium bromide—Diarrhoea—Felbamate—epilepsy syndrome	4.07e-05	0.000362	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lamotrigine—epilepsy syndrome	4.06e-05	0.000362	CcSEcCtD
Ipratropium bromide—Dysgeusia—Gabapentin—epilepsy syndrome	4.06e-05	0.000362	CcSEcCtD
Ipratropium bromide—Dizziness—Diazepam—epilepsy syndrome	4.06e-05	0.000362	CcSEcCtD
Ipratropium bromide—Infection—Valproic Acid—epilepsy syndrome	4.06e-05	0.000361	CcSEcCtD
Ipratropium bromide—Rash—Fosphenytoin—epilepsy syndrome	4.04e-05	0.000359	CcSEcCtD
Ipratropium bromide—Dermatitis—Fosphenytoin—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Ipratropium bromide—Haemoglobin—Topiramate—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Ipratropium bromide—Nervousness—Gabapentin—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Ipratropium bromide—Asthenia—Clonazepam—epilepsy syndrome	4.02e-05	0.000358	CcSEcCtD
Ipratropium bromide—Rhinitis—Topiramate—epilepsy syndrome	4.02e-05	0.000358	CcSEcCtD
Ipratropium bromide—Back pain—Gabapentin—epilepsy syndrome	4.01e-05	0.000357	CcSEcCtD
Ipratropium bromide—Headache—Fosphenytoin—epilepsy syndrome	4.01e-05	0.000357	CcSEcCtD
Ipratropium bromide—Haemorrhage—Topiramate—epilepsy syndrome	4.01e-05	0.000357	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Valproic Acid—epilepsy syndrome	4e-05	0.000356	CcSEcCtD
Ipratropium bromide—Palpitations—Pregabalin—epilepsy syndrome	4e-05	0.000356	CcSEcCtD
Ipratropium bromide—Asthenia—Phenytoin—epilepsy syndrome	4e-05	0.000356	CcSEcCtD
Ipratropium bromide—Nausea—Midazolam—epilepsy syndrome	3.99e-05	0.000355	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Topiramate—epilepsy syndrome	3.99e-05	0.000355	CcSEcCtD
Ipratropium bromide—Tachycardia—Valproic Acid—epilepsy syndrome	3.99e-05	0.000355	CcSEcCtD
Ipratropium bromide—Diarrhoea—Zonisamide—epilepsy syndrome	3.98e-05	0.000354	CcSEcCtD
Ipratropium bromide—Pharyngitis—Topiramate—epilepsy syndrome	3.98e-05	0.000354	CcSEcCtD
Ipratropium bromide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.98e-05	0.000354	CcSEcCtD
Ipratropium bromide—Pruritus—Clonazepam—epilepsy syndrome	3.97e-05	0.000353	CcSEcCtD
Ipratropium bromide—Vomiting—Vigabatrin—epilepsy syndrome	3.97e-05	0.000353	CcSEcCtD
Ipratropium bromide—Skin disorder—Valproic Acid—epilepsy syndrome	3.97e-05	0.000353	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Topiramate—epilepsy syndrome	3.96e-05	0.000352	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.95e-05	0.000351	CcSEcCtD
Ipratropium bromide—Cough—Pregabalin—epilepsy syndrome	3.95e-05	0.000351	CcSEcCtD
Ipratropium bromide—Pruritus—Phenytoin—epilepsy syndrome	3.94e-05	0.000351	CcSEcCtD
Ipratropium bromide—Nausea—Levetiracetam—epilepsy syndrome	3.94e-05	0.000351	CcSEcCtD
Ipratropium bromide—Rash—Vigabatrin—epilepsy syndrome	3.93e-05	0.00035	CcSEcCtD
Ipratropium bromide—Dizziness—Felbamate—epilepsy syndrome	3.93e-05	0.00035	CcSEcCtD
Ipratropium bromide—Dermatitis—Vigabatrin—epilepsy syndrome	3.93e-05	0.00035	CcSEcCtD
Ipratropium bromide—Urethral disorder—Topiramate—epilepsy syndrome	3.93e-05	0.00035	CcSEcCtD
Ipratropium bromide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.92e-05	0.000349	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.92e-05	0.000349	CcSEcCtD
Ipratropium bromide—Vision blurred—Gabapentin—epilepsy syndrome	3.91e-05	0.000348	CcSEcCtD
Ipratropium bromide—Headache—Vigabatrin—epilepsy syndrome	3.91e-05	0.000348	CcSEcCtD
Ipratropium bromide—Hypertension—Pregabalin—epilepsy syndrome	3.91e-05	0.000348	CcSEcCtD
Ipratropium bromide—Vomiting—Diazepam—epilepsy syndrome	3.91e-05	0.000348	CcSEcCtD
Ipratropium bromide—Tremor—Gabapentin—epilepsy syndrome	3.89e-05	0.000346	CcSEcCtD
Ipratropium bromide—Rash—Diazepam—epilepsy syndrome	3.87e-05	0.000345	CcSEcCtD
Ipratropium bromide—Dermatitis—Diazepam—epilepsy syndrome	3.87e-05	0.000344	CcSEcCtD
Ipratropium bromide—Visual impairment—Topiramate—epilepsy syndrome	3.86e-05	0.000344	CcSEcCtD
Ipratropium bromide—Chest pain—Pregabalin—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Ipratropium bromide—Myalgia—Pregabalin—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Ipratropium bromide—Dizziness—Zonisamide—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Ipratropium bromide—Headache—Diazepam—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Ipratropium bromide—Scopolamine—ABCB1—epilepsy syndrome	3.84e-05	0.0109	CrCbGaD
Ipratropium bromide—Diarrhoea—Clonazepam—epilepsy syndrome	3.84e-05	0.000342	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.82e-05	0.00034	CcSEcCtD
Ipratropium bromide—Hypotension—Valproic Acid—epilepsy syndrome	3.82e-05	0.00034	CcSEcCtD
Ipratropium bromide—Asthenia—Carbamazepine—epilepsy syndrome	3.82e-05	0.00034	CcSEcCtD
Ipratropium bromide—Diarrhoea—Phenytoin—epilepsy syndrome	3.81e-05	0.000339	CcSEcCtD
Ipratropium bromide—Nausea—Fosphenytoin—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Ipratropium bromide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.000337	CcSEcCtD
Ipratropium bromide—Angioedema—Gabapentin—epilepsy syndrome	3.79e-05	0.000337	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.79e-05	0.000337	CcSEcCtD
Ipratropium bromide—Vomiting—Felbamate—epilepsy syndrome	3.78e-05	0.000336	CcSEcCtD
Ipratropium bromide—Dry mouth—Pregabalin—epilepsy syndrome	3.77e-05	0.000335	CcSEcCtD
Ipratropium bromide—Pruritus—Carbamazepine—epilepsy syndrome	3.76e-05	0.000335	CcSEcCtD
Ipratropium bromide—Rash—Felbamate—epilepsy syndrome	3.75e-05	0.000334	CcSEcCtD
Ipratropium bromide—Eye disorder—Topiramate—epilepsy syndrome	3.75e-05	0.000333	CcSEcCtD
Ipratropium bromide—Dermatitis—Felbamate—epilepsy syndrome	3.74e-05	0.000333	CcSEcCtD
Ipratropium bromide—Tinnitus—Topiramate—epilepsy syndrome	3.74e-05	0.000333	CcSEcCtD
Ipratropium bromide—Headache—Felbamate—epilepsy syndrome	3.72e-05	0.000332	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Ipratropium bromide—Flushing—Topiramate—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Ipratropium bromide—Dizziness—Clonazepam—epilepsy syndrome	3.71e-05	0.00033	CcSEcCtD
Ipratropium bromide—Nausea—Vigabatrin—epilepsy syndrome	3.71e-05	0.00033	CcSEcCtD
Ipratropium bromide—Vomiting—Zonisamide—epilepsy syndrome	3.7e-05	0.000329	CcSEcCtD
Ipratropium bromide—Insomnia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000329	CcSEcCtD
Ipratropium bromide—Oedema—Pregabalin—epilepsy syndrome	3.69e-05	0.000329	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.69e-05	0.000329	CcSEcCtD
Ipratropium bromide—Asthenia—Lamotrigine—epilepsy syndrome	3.69e-05	0.000328	CcSEcCtD
Ipratropium bromide—Dizziness—Phenytoin—epilepsy syndrome	3.68e-05	0.000328	CcSEcCtD
Ipratropium bromide—Rash—Zonisamide—epilepsy syndrome	3.67e-05	0.000327	CcSEcCtD
Ipratropium bromide—Infection—Pregabalin—epilepsy syndrome	3.67e-05	0.000326	CcSEcCtD
Ipratropium bromide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.67e-05	0.000326	CcSEcCtD
Ipratropium bromide—Palpitations—Gabapentin—epilepsy syndrome	3.67e-05	0.000326	CcSEcCtD
Ipratropium bromide—Dermatitis—Zonisamide—epilepsy syndrome	3.67e-05	0.000326	CcSEcCtD
Ipratropium bromide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.000326	CcSEcCtD
Ipratropium bromide—Nausea—Diazepam—epilepsy syndrome	3.65e-05	0.000325	CcSEcCtD
Ipratropium bromide—Headache—Zonisamide—epilepsy syndrome	3.65e-05	0.000324	CcSEcCtD
Ipratropium bromide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.64e-05	0.000324	CcSEcCtD
Ipratropium bromide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.64e-05	0.000324	CcSEcCtD
Ipratropium bromide—Pruritus—Lamotrigine—epilepsy syndrome	3.64e-05	0.000324	CcSEcCtD
Ipratropium bromide—Somnolence—Valproic Acid—epilepsy syndrome	3.63e-05	0.000323	CcSEcCtD
Ipratropium bromide—Immune system disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Ipratropium bromide—Cough—Gabapentin—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Topiramate—epilepsy syndrome	3.61e-05	0.000322	CcSEcCtD
Ipratropium bromide—Tachycardia—Pregabalin—epilepsy syndrome	3.6e-05	0.000321	CcSEcCtD
Ipratropium bromide—CYP2D6—brain—epilepsy syndrome	3.6e-05	0.00864	CbGeAlD
Ipratropium bromide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.59e-05	0.00032	CcSEcCtD
Ipratropium bromide—Skin disorder—Pregabalin—epilepsy syndrome	3.59e-05	0.000319	CcSEcCtD
Ipratropium bromide—Hypertension—Gabapentin—epilepsy syndrome	3.58e-05	0.000319	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.57e-05	0.000318	CcSEcCtD
Ipratropium bromide—Vomiting—Clonazepam—epilepsy syndrome	3.57e-05	0.000317	CcSEcCtD
Ipratropium bromide—Vomiting—Phenytoin—epilepsy syndrome	3.54e-05	0.000315	CcSEcCtD
Ipratropium bromide—Rash—Clonazepam—epilepsy syndrome	3.54e-05	0.000315	CcSEcCtD
Ipratropium bromide—Dermatitis—Clonazepam—epilepsy syndrome	3.53e-05	0.000314	CcSEcCtD
Ipratropium bromide—Chest pain—Gabapentin—epilepsy syndrome	3.53e-05	0.000314	CcSEcCtD
Ipratropium bromide—Myalgia—Gabapentin—epilepsy syndrome	3.53e-05	0.000314	CcSEcCtD
Ipratropium bromide—Nausea—Felbamate—epilepsy syndrome	3.53e-05	0.000314	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.53e-05	0.000314	CcSEcCtD
Ipratropium bromide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.52e-05	0.000314	CcSEcCtD
Ipratropium bromide—Fatigue—Valproic Acid—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Ipratropium bromide—Dizziness—Carbamazepine—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Ipratropium bromide—Headache—Clonazepam—epilepsy syndrome	3.51e-05	0.000313	CcSEcCtD
Ipratropium bromide—Rash—Phenytoin—epilepsy syndrome	3.51e-05	0.000313	CcSEcCtD
Ipratropium bromide—Dermatitis—Phenytoin—epilepsy syndrome	3.51e-05	0.000312	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.51e-05	0.000312	CcSEcCtD
Ipratropium bromide—Rash—Oxcarbazepine—epilepsy syndrome	3.49e-05	0.000311	CcSEcCtD
Ipratropium bromide—Pain—Valproic Acid—epilepsy syndrome	3.49e-05	0.000311	CcSEcCtD
Ipratropium bromide—Constipation—Valproic Acid—epilepsy syndrome	3.49e-05	0.000311	CcSEcCtD
Ipratropium bromide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.49e-05	0.000311	CcSEcCtD
Ipratropium bromide—Headache—Phenytoin—epilepsy syndrome	3.49e-05	0.000311	CcSEcCtD
Ipratropium bromide—Headache—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000309	CcSEcCtD
Ipratropium bromide—Nausea—Zonisamide—epilepsy syndrome	3.46e-05	0.000308	CcSEcCtD
Ipratropium bromide—Dry mouth—Gabapentin—epilepsy syndrome	3.45e-05	0.000307	CcSEcCtD
Ipratropium bromide—Hypotension—Pregabalin—epilepsy syndrome	3.45e-05	0.000307	CcSEcCtD
Ipratropium bromide—Flatulence—Topiramate—epilepsy syndrome	3.44e-05	0.000306	CcSEcCtD
Ipratropium bromide—Tension—Topiramate—epilepsy syndrome	3.42e-05	0.000305	CcSEcCtD
Ipratropium bromide—Dysgeusia—Topiramate—epilepsy syndrome	3.42e-05	0.000304	CcSEcCtD
Ipratropium bromide—Dizziness—Lamotrigine—epilepsy syndrome	3.4e-05	0.000303	CcSEcCtD
Ipratropium bromide—Nervousness—Topiramate—epilepsy syndrome	3.39e-05	0.000302	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.39e-05	0.000301	CcSEcCtD
Ipratropium bromide—Oedema—Gabapentin—epilepsy syndrome	3.39e-05	0.000301	CcSEcCtD
Ipratropium bromide—Vomiting—Carbamazepine—epilepsy syndrome	3.38e-05	0.000301	CcSEcCtD
Ipratropium bromide—Back pain—Topiramate—epilepsy syndrome	3.38e-05	0.0003	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.36e-05	0.000299	CcSEcCtD
Ipratropium bromide—Infection—Gabapentin—epilepsy syndrome	3.36e-05	0.000299	CcSEcCtD
Ipratropium bromide—Rash—Carbamazepine—epilepsy syndrome	3.35e-05	0.000298	CcSEcCtD
Ipratropium bromide—Dermatitis—Carbamazepine—epilepsy syndrome	3.35e-05	0.000298	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.34e-05	0.000297	CcSEcCtD
Ipratropium bromide—Insomnia—Pregabalin—epilepsy syndrome	3.34e-05	0.000297	CcSEcCtD
Ipratropium bromide—Nausea—Clonazepam—epilepsy syndrome	3.33e-05	0.000297	CcSEcCtD
Ipratropium bromide—Headache—Carbamazepine—epilepsy syndrome	3.33e-05	0.000297	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.32e-05	0.000296	CcSEcCtD
Ipratropium bromide—Paraesthesia—Pregabalin—epilepsy syndrome	3.32e-05	0.000295	CcSEcCtD
Ipratropium bromide—Nausea—Phenytoin—epilepsy syndrome	3.31e-05	0.000295	CcSEcCtD
Ipratropium bromide—Tachycardia—Gabapentin—epilepsy syndrome	3.3e-05	0.000294	CcSEcCtD
Ipratropium bromide—Dyspnoea—Pregabalin—epilepsy syndrome	3.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Nausea—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Vision blurred—Topiramate—epilepsy syndrome	3.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Skin disorder—Gabapentin—epilepsy syndrome	3.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Somnolence—Pregabalin—epilepsy syndrome	3.28e-05	0.000292	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.27e-05	0.000291	CcSEcCtD
Ipratropium bromide—Tremor—Topiramate—epilepsy syndrome	3.27e-05	0.000291	CcSEcCtD
Ipratropium bromide—Vomiting—Lamotrigine—epilepsy syndrome	3.27e-05	0.000291	CcSEcCtD
Ipratropium bromide—Urticaria—Valproic Acid—epilepsy syndrome	3.24e-05	0.000289	CcSEcCtD
Ipratropium bromide—Rash—Lamotrigine—epilepsy syndrome	3.24e-05	0.000288	CcSEcCtD
Ipratropium bromide—Dermatitis—Lamotrigine—epilepsy syndrome	3.24e-05	0.000288	CcSEcCtD
Ipratropium bromide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.23e-05	0.000287	CcSEcCtD
Ipratropium bromide—Headache—Lamotrigine—epilepsy syndrome	3.22e-05	0.000287	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.19e-05	0.000284	CcSEcCtD
Ipratropium bromide—Fatigue—Pregabalin—epilepsy syndrome	3.18e-05	0.000283	CcSEcCtD
Ipratropium bromide—Hypotension—Gabapentin—epilepsy syndrome	3.16e-05	0.000282	CcSEcCtD
Ipratropium bromide—Nausea—Carbamazepine—epilepsy syndrome	3.16e-05	0.000281	CcSEcCtD
Ipratropium bromide—Pain—Pregabalin—epilepsy syndrome	3.16e-05	0.000281	CcSEcCtD
Ipratropium bromide—Constipation—Pregabalin—epilepsy syndrome	3.16e-05	0.000281	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.08e-05	0.000275	CcSEcCtD
Ipratropium bromide—Palpitations—Topiramate—epilepsy syndrome	3.08e-05	0.000275	CcSEcCtD
Ipratropium bromide—Insomnia—Gabapentin—epilepsy syndrome	3.06e-05	0.000273	CcSEcCtD
Ipratropium bromide—Nausea—Lamotrigine—epilepsy syndrome	3.05e-05	0.000272	CcSEcCtD
Ipratropium bromide—Cough—Topiramate—epilepsy syndrome	3.05e-05	0.000271	CcSEcCtD
Ipratropium bromide—Paraesthesia—Gabapentin—epilepsy syndrome	3.04e-05	0.000271	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.02e-05	0.000269	CcSEcCtD
Ipratropium bromide—Dyspnoea—Gabapentin—epilepsy syndrome	3.02e-05	0.000269	CcSEcCtD
Ipratropium bromide—Hypertension—Topiramate—epilepsy syndrome	3.01e-05	0.000268	CcSEcCtD
Ipratropium bromide—Somnolence—Gabapentin—epilepsy syndrome	3.01e-05	0.000268	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.01e-05	0.000268	CcSEcCtD
Ipratropium bromide—Dyspepsia—Gabapentin—epilepsy syndrome	2.98e-05	0.000265	CcSEcCtD
Ipratropium bromide—Chest pain—Topiramate—epilepsy syndrome	2.97e-05	0.000264	CcSEcCtD
Ipratropium bromide—Myalgia—Topiramate—epilepsy syndrome	2.97e-05	0.000264	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.95e-05	0.000263	CcSEcCtD
Ipratropium bromide—Urticaria—Pregabalin—epilepsy syndrome	2.93e-05	0.000261	CcSEcCtD
Ipratropium bromide—Asthenia—Valproic Acid—epilepsy syndrome	2.93e-05	0.000261	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.92e-05	0.00026	CcSEcCtD
Ipratropium bromide—Fatigue—Gabapentin—epilepsy syndrome	2.92e-05	0.00026	CcSEcCtD
Ipratropium bromide—Abdominal pain—Pregabalin—epilepsy syndrome	2.92e-05	0.00026	CcSEcCtD
Ipratropium bromide—Dry mouth—Topiramate—epilepsy syndrome	2.91e-05	0.000259	CcSEcCtD
Ipratropium bromide—Pain—Gabapentin—epilepsy syndrome	2.9e-05	0.000258	CcSEcCtD
Ipratropium bromide—Constipation—Gabapentin—epilepsy syndrome	2.9e-05	0.000258	CcSEcCtD
Ipratropium bromide—Pruritus—Valproic Acid—epilepsy syndrome	2.89e-05	0.000257	CcSEcCtD
Ipratropium bromide—Oedema—Topiramate—epilepsy syndrome	2.85e-05	0.000254	CcSEcCtD
Ipratropium bromide—Infection—Topiramate—epilepsy syndrome	2.83e-05	0.000252	CcSEcCtD
Ipratropium bromide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.79e-05	0.000249	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000249	CcSEcCtD
Ipratropium bromide—Tachycardia—Topiramate—epilepsy syndrome	2.78e-05	0.000247	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.77e-05	0.000246	CcSEcCtD
Ipratropium bromide—Skin disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000246	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Topiramate—epilepsy syndrome	2.75e-05	0.000245	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.72e-05	0.000242	CcSEcCtD
Ipratropium bromide—Dizziness—Valproic Acid—epilepsy syndrome	2.7e-05	0.00024	CcSEcCtD
Ipratropium bromide—Urticaria—Gabapentin—epilepsy syndrome	2.69e-05	0.000239	CcSEcCtD
Ipratropium bromide—Abdominal pain—Gabapentin—epilepsy syndrome	2.68e-05	0.000238	CcSEcCtD
Ipratropium bromide—Hypotension—Topiramate—epilepsy syndrome	2.66e-05	0.000237	CcSEcCtD
Ipratropium bromide—Asthenia—Pregabalin—epilepsy syndrome	2.65e-05	0.000236	CcSEcCtD
Ipratropium bromide—Pruritus—Pregabalin—epilepsy syndrome	2.61e-05	0.000233	CcSEcCtD
Ipratropium bromide—Vomiting—Valproic Acid—epilepsy syndrome	2.6e-05	0.000231	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.59e-05	0.000231	CcSEcCtD
Ipratropium bromide—Insomnia—Topiramate—epilepsy syndrome	2.58e-05	0.000229	CcSEcCtD
Ipratropium bromide—Rash—Valproic Acid—epilepsy syndrome	2.57e-05	0.000229	CcSEcCtD
Ipratropium bromide—Dermatitis—Valproic Acid—epilepsy syndrome	2.57e-05	0.000229	CcSEcCtD
Ipratropium bromide—Headache—Valproic Acid—epilepsy syndrome	2.56e-05	0.000228	CcSEcCtD
Ipratropium bromide—Paraesthesia—Topiramate—epilepsy syndrome	2.56e-05	0.000228	CcSEcCtD
Ipratropium bromide—Dyspnoea—Topiramate—epilepsy syndrome	2.54e-05	0.000226	CcSEcCtD
Ipratropium bromide—Somnolence—Topiramate—epilepsy syndrome	2.53e-05	0.000225	CcSEcCtD
Ipratropium bromide—Diarrhoea—Pregabalin—epilepsy syndrome	2.53e-05	0.000225	CcSEcCtD
Ipratropium bromide—Dyspepsia—Topiramate—epilepsy syndrome	2.51e-05	0.000223	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.49e-05	0.000222	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.46e-05	0.000219	CcSEcCtD
Ipratropium bromide—Fatigue—Topiramate—epilepsy syndrome	2.46e-05	0.000219	CcSEcCtD
Ipratropium bromide—Dizziness—Pregabalin—epilepsy syndrome	2.44e-05	0.000217	CcSEcCtD
Ipratropium bromide—Pain—Topiramate—epilepsy syndrome	2.44e-05	0.000217	CcSEcCtD
Ipratropium bromide—Constipation—Topiramate—epilepsy syndrome	2.44e-05	0.000217	CcSEcCtD
Ipratropium bromide—Asthenia—Gabapentin—epilepsy syndrome	2.43e-05	0.000216	CcSEcCtD
Ipratropium bromide—Nausea—Valproic Acid—epilepsy syndrome	2.43e-05	0.000216	CcSEcCtD
Ipratropium bromide—Pruritus—Gabapentin—epilepsy syndrome	2.4e-05	0.000213	CcSEcCtD
Ipratropium bromide—Vomiting—Pregabalin—epilepsy syndrome	2.35e-05	0.000209	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.33e-05	0.000207	CcSEcCtD
Ipratropium bromide—Rash—Pregabalin—epilepsy syndrome	2.33e-05	0.000207	CcSEcCtD
Ipratropium bromide—Dermatitis—Pregabalin—epilepsy syndrome	2.33e-05	0.000207	CcSEcCtD
Ipratropium bromide—Diarrhoea—Gabapentin—epilepsy syndrome	2.32e-05	0.000206	CcSEcCtD
Ipratropium bromide—Headache—Pregabalin—epilepsy syndrome	2.31e-05	0.000206	CcSEcCtD
Ipratropium bromide—Urticaria—Topiramate—epilepsy syndrome	2.26e-05	0.000201	CcSEcCtD
Ipratropium bromide—Abdominal pain—Topiramate—epilepsy syndrome	2.25e-05	0.0002	CcSEcCtD
Ipratropium bromide—Dizziness—Gabapentin—epilepsy syndrome	2.24e-05	0.000199	CcSEcCtD
Ipratropium bromide—Nausea—Pregabalin—epilepsy syndrome	2.19e-05	0.000195	CcSEcCtD
Ipratropium bromide—Vomiting—Gabapentin—epilepsy syndrome	2.15e-05	0.000192	CcSEcCtD
Ipratropium bromide—Rash—Gabapentin—epilepsy syndrome	2.13e-05	0.00019	CcSEcCtD
Ipratropium bromide—Dermatitis—Gabapentin—epilepsy syndrome	2.13e-05	0.00019	CcSEcCtD
Ipratropium bromide—Headache—Gabapentin—epilepsy syndrome	2.12e-05	0.000189	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Topiramate—epilepsy syndrome	2.1e-05	0.000187	CcSEcCtD
Ipratropium bromide—Asthenia—Topiramate—epilepsy syndrome	2.04e-05	0.000182	CcSEcCtD
Ipratropium bromide—Pruritus—Topiramate—epilepsy syndrome	2.02e-05	0.000179	CcSEcCtD
Ipratropium bromide—Nausea—Gabapentin—epilepsy syndrome	2.01e-05	0.000179	CcSEcCtD
Ipratropium bromide—Diarrhoea—Topiramate—epilepsy syndrome	1.95e-05	0.000173	CcSEcCtD
Ipratropium bromide—Dizziness—Topiramate—epilepsy syndrome	1.88e-05	0.000168	CcSEcCtD
Ipratropium bromide—Vomiting—Topiramate—epilepsy syndrome	1.81e-05	0.000161	CcSEcCtD
Ipratropium bromide—Rash—Topiramate—epilepsy syndrome	1.8e-05	0.00016	CcSEcCtD
Ipratropium bromide—Dermatitis—Topiramate—epilepsy syndrome	1.79e-05	0.00016	CcSEcCtD
Ipratropium bromide—Headache—Topiramate—epilepsy syndrome	1.78e-05	0.000159	CcSEcCtD
Ipratropium bromide—Nausea—Topiramate—epilepsy syndrome	1.69e-05	0.000151	CcSEcCtD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.86e-06	7.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	3.85e-06	7.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	3.85e-06	7.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HES1—epilepsy syndrome	3.83e-06	7.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.82e-06	7.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	3.82e-06	7.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	3.82e-06	7.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	3.81e-06	7.64e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	3.8e-06	7.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	3.76e-06	7.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	3.76e-06	7.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SST—epilepsy syndrome	3.76e-06	7.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	3.76e-06	7.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SST—epilepsy syndrome	3.75e-06	7.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	3.75e-06	7.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	3.75e-06	7.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	3.73e-06	7.48e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FYN—epilepsy syndrome	3.72e-06	7.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	3.71e-06	7.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	3.71e-06	7.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	3.71e-06	7.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	3.71e-06	7.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—H2AFX—epilepsy syndrome	3.71e-06	7.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MEF2C—epilepsy syndrome	3.7e-06	7.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.69e-06	7.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.68e-06	7.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	3.68e-06	7.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	3.67e-06	7.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	3.66e-06	7.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	3.65e-06	7.33e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	3.63e-06	7.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	3.62e-06	7.26e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.59e-06	7.2e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	3.58e-06	7.18e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NGF—epilepsy syndrome	3.54e-06	7.1e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.53e-06	7.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	3.53e-06	7.09e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	3.53e-06	7.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	3.52e-06	7.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	3.52e-06	7.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.52e-06	7.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	3.52e-06	7.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	3.51e-06	7.04e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.5e-06	7.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.5e-06	7.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.5e-06	7.01e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	3.49e-06	7.01e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	3.49e-06	7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	3.49e-06	7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	3.48e-06	6.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.47e-06	6.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	3.47e-06	6.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	3.47e-06	6.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.46e-06	6.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	3.46e-06	6.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	3.46e-06	6.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	3.46e-06	6.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	3.45e-06	6.91e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	3.44e-06	6.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—HMOX1—epilepsy syndrome	3.43e-06	6.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	3.43e-06	6.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	3.43e-06	6.87e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	3.41e-06	6.85e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	3.39e-06	6.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CAT—epilepsy syndrome	3.38e-06	6.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	3.37e-06	6.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	3.37e-06	6.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	3.34e-06	6.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.34e-06	6.69e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.34e-06	6.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ABCB1—epilepsy syndrome	3.29e-06	6.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	3.29e-06	6.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	3.28e-06	6.57e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.26e-06	6.55e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	3.24e-06	6.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	3.23e-06	6.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	3.22e-06	6.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	3.21e-06	6.43e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	3.2e-06	6.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.2e-06	6.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	3.2e-06	6.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	3.19e-06	6.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	3.18e-06	6.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	3.16e-06	6.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.15e-06	6.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	3.15e-06	6.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	3.14e-06	6.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	3.14e-06	6.29e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.14e-06	6.29e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	3.13e-06	6.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	3.13e-06	6.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.11e-06	6.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.1e-06	6.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.08e-06	6.17e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.07e-06	6.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	3.07e-06	6.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX1—epilepsy syndrome	3.06e-06	6.13e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.05e-06	6.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	2.98e-06	5.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	2.97e-06	5.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	2.95e-06	5.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.95e-06	5.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	2.94e-06	5.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	2.94e-06	5.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	2.94e-06	5.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	2.94e-06	5.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	2.93e-06	5.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	2.91e-06	5.84e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	2.91e-06	5.83e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.88e-06	5.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	2.85e-06	5.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	2.84e-06	5.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	2.81e-06	5.64e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.8e-06	5.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	2.69e-06	5.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	2.69e-06	5.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	2.69e-06	5.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AGT—epilepsy syndrome	2.68e-06	5.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	2.66e-06	5.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	2.63e-06	5.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOE—epilepsy syndrome	2.63e-06	5.27e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.62e-06	5.26e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	2.62e-06	5.26e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	2.61e-06	5.24e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.61e-06	5.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.61e-06	5.24e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.61e-06	5.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	2.6e-06	5.22e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	2.6e-06	5.21e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	2.59e-06	5.19e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	2.58e-06	5.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	2.57e-06	5.16e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.53e-06	5.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.53e-06	5.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.52e-06	5.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	2.51e-06	5.04e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.49e-06	5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	2.49e-06	5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.49e-06	4.99e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	2.48e-06	4.98e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.46e-06	4.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	2.46e-06	4.93e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TH—epilepsy syndrome	2.46e-06	4.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.42e-06	4.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	2.41e-06	4.84e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	2.39e-06	4.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	2.38e-06	4.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.37e-06	4.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	2.36e-06	4.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.34e-06	4.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—epilepsy syndrome	2.26e-06	4.53e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.25e-06	4.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	2.25e-06	4.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	2.25e-06	4.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	2.24e-06	4.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.22e-06	4.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.22e-06	4.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	2.21e-06	4.43e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.2e-06	4.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.2e-06	4.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.18e-06	4.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.16e-06	4.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.16e-06	4.33e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.15e-06	4.32e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.13e-06	4.28e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.08e-06	4.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.07e-06	4.16e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.07e-06	4.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.06e-06	4.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.06e-06	4.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—epilepsy syndrome	2.06e-06	4.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.05e-06	4.12e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.05e-06	4.11e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.04e-06	4.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.02e-06	4.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.01e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.01e-06	4.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2e-06	4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	1.99e-06	3.99e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.97e-06	3.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	1.93e-06	3.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.89e-06	3.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	1.89e-06	3.79e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	1.88e-06	3.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	1.87e-06	3.75e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.85e-06	3.72e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	1.85e-06	3.7e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	1.83e-06	3.67e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.83e-06	3.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	1.82e-06	3.66e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.8e-06	3.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—epilepsy syndrome	1.8e-06	3.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	1.73e-06	3.48e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.71e-06	3.44e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.71e-06	3.43e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	1.69e-06	3.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.67e-06	3.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.67e-06	3.35e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.65e-06	3.32e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.63e-06	3.27e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.61e-06	3.23e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.61e-06	3.22e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.6e-06	3.22e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.57e-06	3.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.55e-06	3.12e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1.55e-06	3.11e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.53e-06	3.08e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.52e-06	3.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	1.52e-06	3.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.5e-06	3.02e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.41e-06	2.84e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.41e-06	2.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.4e-06	2.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.4e-06	2.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.4e-06	2.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.38e-06	2.78e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.36e-06	2.73e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.36e-06	2.72e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.35e-06	2.71e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.34e-06	2.7e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	2.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.32e-06	2.66e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.32e-06	2.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.32e-06	2.65e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.31e-06	2.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	2.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.28e-06	2.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.28e-06	2.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.27e-06	2.54e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.23e-06	2.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.22e-06	2.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.22e-06	2.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.21e-06	2.42e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.2e-06	2.4e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.19e-06	2.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.19e-06	2.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.17e-06	2.36e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.08e-06	2.16e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	2.16e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.05e-06	2.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.03e-06	2.06e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—epilepsy syndrome	9.05e-07	1.82e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.82e-07	1.77e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.04e-07	1.61e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	7.59e-07	1.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	7.57e-07	1.52e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	7.49e-07	1.5e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.04e-07	1.41e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.41e-07	1.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.54e-07	7.1e-06	CbGpPWpGaD
